Safety & Efficacy of the J-Valve Ausper System in Patients With Severe Aortic Stenosis and/or Aortic Regurgitation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.
Also called NCT03025971
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 107 participants
- Sponsor
- JC Medical, Inc., an affiliate of Edwards Lifesciences LLC
- Registry
-
NCT03025971
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03025971. Allocation not applicable; no masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2016-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety & Efficacy of the J-Valve Ausper System in Patients With Severe Aortic Stenosis and/or Aortic Regurgitation
- Condition
- Aortic Valve Disease
- Intervention (Device)
- J-Valve Transcatheter Aortic valve replacement
- Lead sponsor
- JC Medical, Inc., an affiliate of Edwards Lifesciences LLC
Record details
- Record id
cardio:ct-nct03025971- Content hash
a201bcc4e5c962e49f4bfdee5129a840773866933f08f54a2a3118d219f52750